Cancer doesn’t evolve by pure chaos. Scientists have developed a powerful new method that reveals the hidden rules guiding how cancer cells gain and lose whole chromosomes—massive genetic shifts that ...

Real-world clinical outcome of sacituzumab govitecan (SG) in HER2-negative metastatic breast cancer. Assessing venous thromboembolism risk in HR+/HER2- breast cancer patients receiving CDK4/6 ...

Researchers at Moffitt Cancer Center have developed a new way to predict how cancer cells evolve by gaining and losing whole ...

Cancer does not develop overnight. It can take decades for cancer-promoting changes in the genome to eventually lead to the formation of a malignant tumor. Researchers at the German Cancer Research ...

Cancer has long been portrayed as a disease of pure genetic chaos, a biological roulette that makes every tumor feel uniquely ...

EVOFLUx uses DNA methylation fluctuations as molecular barcodes to trace tumor evolution, offering insights into growth, treatment resistance, and prognosis. The method requires only bulk methylation ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Before trastuzumab-deruxtecan, we didn't ...

Key HighlightsResearchers developed a new method to predict how cancer cells evolve by gaining or losing whole chromosomes.

Modern cancer care has shifted toward a patient-centred approach that focuses on early detection, prevention, and preserving ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. The breast cancer treatment landscape has ...